Literature DB >> 8031798

Cardiac function after orthotopic heart transplantation: response to postural changes, exercise, and beta-adrenergic blockade.

M S Verani1, S Nishimura, J J Mahmarian, J T Hays, J B Young.   

Abstract

To prospectively assess the response of orthotopic heart transplant recipients to exercise before and after beta-adrenergic blockade, we investigated 35 orthotopic heart recipients, all with clinically stable conditions and without rejection, and five control, healthy subjects. Radionuclide angiography was performed at rest and during supine bicycle exercise, before and after beta-blockade. At rest, heart rate, systolic and diastolic pressures, and end-systolic volume were higher, whereas the end-diastolic volume and stroke volume indexes, cardiac index, and ejection fraction were significantly lower in the transplant recipients than in healthy control subjects. During exercise, before beta-blockade, transplant recipients attained a lower maximal heart rate and smaller increments in heart rate than did the control subjects. The cardiac index increased during exercise because of an increase in stroke volume (43%) and heart rate (32%) in the transplant recipients and nearly exclusively (93%) because of an increase in heart rate in the normal subjects. After beta-blockade, the ejection fraction, the stroke volume, and the cardiac index fell significantly at rest in both groups. The fall in ejection fraction was greater in the transplant recipients than in the control subjects (-16% +/- 12.6% versus -5.4% +/- 2.6%, respectively; p = 0.0002). After beta-blockade, lower maximal heart rate, ejection fraction, and cardiac index were achieved during exercise in both groups. The peak exercise cardiac index was 42% lower in transplant recipients than in control subjects after beta-blockade. Thus, cardiac performance during exercise is impaired in orthotopic heart transplant recipients. Acute beta-adrenergic blockade accentuates the impairment in ventricular performance and appears to be detrimental in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031798

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

1.  Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.

Authors:  R Zhang; A Haverich; M Strüber; A Simon; M Pichlmaier; Christoph Bara
Journal:  Clin Res Cardiol       Date:  2008-07-21       Impact factor: 5.460

2.  Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.

Authors:  Michal Pazdernik; Dan Wichterle; Zhi Chen; Helena Bedanova; Josef Kautzner; Vojtech Melenovsky; Vladimir Karmazin; Ivan Malek; Peter Stiavnicky; Ales Tomasek; Eva Ozabalova; Jan Krejci; Andreas Wahle; Honghai Zhang; Tomas Kovarnik; Milan Sonka
Journal:  Clin Transplant       Date:  2020-01-09       Impact factor: 2.863

3.  Should we consider heart rate reduction in cardiac transplant recipients?

Authors:  Baskar Sekar; William R Critchley; Simon G Williams; Steven M Shaw
Journal:  Clin Cardiol       Date:  2012-08-21       Impact factor: 2.882

4.  Haemodynamic responses to exercise, ATP infusion and thigh compression in humans: insight into the role of muscle mechanisms on cardiovascular function.

Authors:  José González-Alonso; Stefan P Mortensen; Tina D Jeppesen; Leena Ali; Horace Barker; Rasmus Damsgaard; Niels H Secher; Ellen A Dawson; Stéphane P Dufour
Journal:  J Physiol       Date:  2008-03-13       Impact factor: 5.182

5.  Double Product and Autonomic Function as Predictors of Quality of Life in Heart Transplant Recipients: A Cross-Sectional Study.

Authors:  Luiz Fernando Rodrigues; Beatriz Robert Moreira; Alice Pereira Duque; Juliana Rega de Oliveira; Pedro Henrique Scheidt Figueiredo; Cláudia Rosa de Oliveira; Alexandre Siciliano Colafranceschi; Mauro Felippe Felix Mediano; Tereza Cristina Felippe Guimarães
Journal:  Braz J Cardiovasc Surg       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.